Cargando…

Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients

BACKGROUND: Adenomyosis is a cause of chronic pelvic pain in women of reproductive age. The aim of this study was to investigate the effects of subcutaneous etonogestrel implantation on adenomyosis. MATERIAL/METHODS: A clinical observational study included 17 women with adenomyosis who were treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jianbo, Huang, Yuxiu, Chen, Lihong, Hu, Jifen, Zou, Yilu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130172/ https://www.ncbi.nlm.nih.gov/pubmed/30171680 http://dx.doi.org/10.12659/MSM.908979

Ejemplares similares

Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study
por: Niu, Xiaocen, et al.
Publicado: (2021)

Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria
por: Moeti, Dikonketjo M.P., et al.
Publicado: (2022)

Subcutaneous implant with etonogestrel (Implanon®) for catamenial exacerbations in a patient with cystic fibrosis: a case report
por: Lamas, Adelaida, et al.
Publicado: (2014)

Etonogestrel Implant—To Leave or Stay: A Case Series
por: Thew, Margaret
Publicado: (2017)

Diagnosis of Intrauterine Pregnancy Despite the Presence of Etonogestrel Implant
por: Sawyers, Ryan J, et al.
Publicado: (2022)

Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives
por: Meece, Frederick A., et al.
Publicado: (2018)

Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
por: Hohmann, Heather
Publicado: (2009)

Continuation Rates of the Etonogestrel Implant and Factors Associated With Early Discontinuation
por: Hines, Genesis, et al.
Publicado: (2023)

Three-year observational study of immediate post-abortion insertion versus menstrual insertion of etonogestrel contraceptive implant
por: Zheng, Wanren, et al.
Publicado: (2021)

Toxic epidermal necrolysis caused by etonogestrel implantation: A rare presentation
por: Amin, Minorvi, et al.
Publicado: (2022)

Infective Endocarditis in Hypertrophic Obstructive Cardiomyopathy After Etonogestrel Implant Removal
por: Dlewati, Mohammad M, et al.
Publicado: (2022)

Considerations in Adolescent Use of the Etonogestrel Subdermal Implant: A Cohort Study
por: Fei, Y. Frances, et al.
Publicado: (2021)

A Comparison of Breastfeeding Exclusivity and Duration Rates Between Immediate Postpartum Levonorgestrel Versus Etonogestrel Implant Users: A Prospective Cohort Study
por: Krashin, Jamie W., et al.
Publicado: (2019)

Decreased efficacy of an etonogestrel implant in a woman on antiepileptic medications: a case report
por: Lange, Jill, et al.
Publicado: (2014)

Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood
por: Haddad, Lisa B., et al.
Publicado: (2020)

Etonogestrel contraceptive implant failure in a woman taking rifampin: a case report
por: Tufa, Tesfaye H., et al.
Publicado: (2022)

A case report on variegate porphyria after etonogestrel placement
por: Strome, Arianna, et al.
Publicado: (2022)

Triptorelin for the treatment of adenomyosis: A multicenter observational study of 465 women in Russia
por: Andreeva, Elena, et al.
Publicado: (2020)

A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant
por: Moray, Kusum V., et al.
Publicado: (2021)

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
por: Ali, Moazzam, et al.
Publicado: (2016)

A clinical scoring system for the diagnosis of adenomyosis
por: Yıldırır, Muhammet, et al.
Publicado: (2022)

Prophylactic temporary abdominal aorta balloon occlusion in women with placenta previa accretism during late gestation
por: Qiu, Zhongyuan, et al.
Publicado: (2017)

A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants
por: Monteiro-Dantas, Cecilia, et al.
Publicado: (2007)

Three-dimensional ultrasound manifestations of adenomyosis
por: Ahmadi, Firoozeh, et al.
Publicado: (2013)

Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway
por: Chen, Lihong, et al.
Publicado: (2018)

Portal Venous Thrombosis Associated with Use of Etonogestrel/ethinyl Estradiol Vaginal Ring
por: Bailey, Katelynn E., et al.
Publicado: (2020)

Procedure, management, and outcome of subcutaneous implantable cardioverter–defibrillator extraction in clinical practice
por: De Filippo, Paolo, et al.
Publicado: (2023)

Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator
por: Francia, Pietro, et al.
Publicado: (2023)

Reversible median nerve neuropathy and local muscle irritation resulting from blind removal attempts of etonogestrel contraceptive implant: a case report
por: Fungtammasan, Siraphat, et al.
Publicado: (2023)

Diagnosis and treatment of adenomyosis
por: Dason, (Ebernella) Shirin, et al.
Publicado: (2021)

Cerebral Sinus Venous Thrombosis in a Patient Using Etonogestrel/Ethinyl Estradiol Vaginal Ring
por: Selim, Mohammad, et al.
Publicado: (2018)

The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis
por: Harada, Tasuku, et al.
Publicado: (2023)

The learning curve associated with the introduction of the subcutaneous implantable defibrillator
por: Knops, Reinoud E., et al.
Publicado: (2016)

Determinants of early discontinuation of etonogestrel sub-dermal implant among reproductive-age women in Legambo district, Northeast Ethiopia: An unmatched case–control study
por: Yimer, Yesuf, et al.
Publicado: (2022)

Infertility and Adenomyosis
por: Campo, Sebastiano, et al.
Publicado: (2012)

Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial
por: Lombardi Fäh, Valeria, et al.
Publicado: (2023)

Clinicopathological Characteristics of Ten Patients with Atypical Glandular Hyperplasia Transformation of Adenomyosis
por: Zhu, Hong-Lan, et al.
Publicado: (2016)

Drug therapy for adenomyosis: a prospective, nonrandomized, parallel-controlled study
por: Li, Qing, et al.
Publicado: (2018)

How adenomyosis changes throughout pregnancy: A retrospective cohort study
por: Bertucci, Emma, et al.
Publicado: (2022)

Fertility and Pregnancy Outcomes in Patients With Adenomyosis: Is Adenomyosis Synonymous With Infertility?
por: Calero, Maria Jose, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8lvo2i784d917npsr5smhgu0ti